FDA expands data mining contract
Executive Summary
FDA is renewing a contract to allow the Office of Drug Safety to access San Diego-based Premier's database for inpatient drug utilization information. The agency is also awarding a contract that would allow the Division of Pediatric Drug Development to use Premier's pediatric inpatient data. The utilization data provides context for adverse event reports, modeling of drug risk based on usage patterns and calculating reporting rates for inpatient drug use, Premier said. FDA first contracted for access to Premier's inpatient data in 2001; the agency previously used the Child Health Corporation of America database for pediatric information (1"The Pink Sheet" Oct. 22, 2001, p. 9)...
You may also be interested in...
Off-Label Pediatric Drug Use To Be Tracked Through FDA Database Contracts
Off-label drug use in pediatric patients will be tracked under FDA contracts for longitudinal prescription data.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip